학술논문

ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer
Document Type
Practice Guideline
Source
In Annals of Oncology December 2020 31(12):1606-1622
Subject
Language
ISSN
0923-7534